Please find attached intimation regarding participation in investor conference
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has disclosed that its management will participate in investor conferences on June 1-2, 2026 in Mumbai. The company will attend a Bank of America-organized group meeting on June 1 and meet with various investors on June 2. The Bank of America conference was finalized at short notice. The company has confirmed that no unpublished price sensitive information will be shared during these meetings, and discussions will be limited to publicly available business outlook. This is a routine regulatory intimation under SEBI LODR regulations.
No material impact on shareholders or stock price. This is a standard investor relations disclosure confirming routine management participation in investor meetings.